This trial will test whether adding tamibarotene to the 2 other drugs helps people with this specific type of leukemia live longer.
2 Primary · 14 Secondary · Reporting Duration: up to 3 years
Active Control
Experimental Treatment
95 Total Participants · 7 Treatment Groups
Primary Treatment: SY-1425 · No Placebo Group · Phase 2
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: